Sol-Gel Technologies Ltd.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Sol-Gel Technologies is a clinical- and commercial-stage pharmaceutical company that develops topical dermatological treatments, using its proprietary silica-based microencapsulation technology to create products for conditions such as acne, rosacea, and skin cancer.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Opaleye Management Inc.10% Owner | Buy | $1.38M | 20,113at $68.42 | Aug 28, 2026 |
| Opaleye Management Inc.10% Owner | Buy | $714K | 10,000at $71.40 | Aug 28, 2026 |
| Opaleye Management Inc.10% Owner | Buy | $344K | 5,000at $68.81 | Aug 28, 2026 |
| Opaleye Management Inc.10% Owner | Buy | $341K | 5,000at $68.23 | Aug 31, 2026 |
| Opaleye Management Inc.10% Owner | Buy | $15K | 217at $69.10 | Aug 31, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable SLGL activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.